KDM2-based delta age
1 paper3 findings
- Humans1
Effects
1Cardiovascular disease mortality prediction
upin humans1
1 study
Cardiovascular disease mortality prediction
upin humans1
KDM2-based delta age improves cardiovascular disease mortality prediction in humans (YCS: NRI 7.9%, IDI 0.4%; JCS: NRI 9.1%, IDI 0.7%; P < 0.001).
“Incorporating KDM2-based DA into the traditional risk factors model significantly improved the prediction of CVD death”
HumansAdded to the traditional risk factors model in Yixing and Jurong cohorts
GeroScience13 Sep 2025
Associations
2Mortality
upin humans1HR 1.089
1 study
Mortality
upin humans1HR 1.089
KDM2-based delta age is associated with mortality in humans (HR 1.089, 95% CI 1.050–1.129).
“and all-cause death (YCS: HR(95% CI) = 1.203(1.075-1.346); JCS: HR(95% CI) = 1.089 (1.050-1.129); P < 0.05).”
HumansExternal validation in the Jurong Cohort Studyn = 16,652
GeroScience13 Sep 2025
Cardiovascular disease mortality
upin humans1HR 1.167
1 study
Cardiovascular disease mortality
upin humans1HR 1.167
KDM2-based delta age is associated with cardiovascular disease mortality in humans (HR 1.167, 95% CI 1.101–1.236).
“showing the strongest association with CVD death (YCS: HR(95% CI) = 1.325 (1.060-1.656); JCS: HR(95% CI) = 1.167(1.101-1.236); P < 0.05)”
HumansExternal validation in the Jurong Cohort Studyn = 16,652
GeroScience13 Sep 2025